Search

The acceptance of serology data instead of challenge for market release of new batches of commercial vaccine is under evaluation by regulatory agencies in order to reduce the use of animals and costs for manufacturers. In this study two vaccines for Bluetongue virus serotype 8 were submitted to quality controls required by the European Pharmacopoeia and tested on sheep in comparison with a commercial inactivated vaccine. Body temperature, antibody titres and viraemia of vaccinated and controls sheep were recorded. In addition IL4 and IFNγ in sera and supernatant derived from in vitro stimulation of blood cells were also quantified using two commercial ELISA kit. The outer-capsid protein VP2 contained in vaccine formulations was quantified using a home-made capture-ELISA. Results obtained indicates that in-lab evaluation of cell-mediated and humoral immune response are useful parameters to predict the efficacy of BTV inactivated vaccines avoiding the challenge phase required to release new batches of vaccines with proven clinical efficacy and safety. The correlation observed between serology data and VP2 protein concentration of final product could be useful in-process control to predict if a new vaccine batch of BTV must be discarded or released to the market.

Detection methods for Mycobacterium avium subsp. paratuberculosis (MAP) are imperfect, yet crucial for diagnosis of Johne's disease. Our purpose was to test for significant and biologically relevant changes in Johne's ELISA results associated with how field-collected blood samples were transported to the laboratory, prepared and stored prior to testing, while removing potential confounding by test kit and laboratory variables. Blood samples were collected from 21 cows that previously had MAP ELISA scores ranging from negative to highly positive. Samples for immediate laboratory processing were subjected to different transportation temperatures (on ice, 26 degrees C) and preparation methods (serum separated, hemolyzed and serum separated, clotted whole blood), but were tested using the same ELISA kit in the same laboratory. Samples for laboratory processing after one week of storage were subjected to different storage temperatures (4 degrees C, -20 degrees C) and preparation methods (serum separated, hemolyzed and serum separated, clotted whole blood), and again were tested using the same ELISA kit in the same laboratory. Finally, samples were evaluated by time to processing (one day, one week) and storage temperature (4 degrees C, -20 degrees C). Data were checked for normality and analyzed with repeated measures ANOVAs. Significantly (P=0.027) higher MAP ELISA scores were recorded for whole blood and hemolyzed samples transported at 26 degrees C than serum separated samples. Sample storage for one week at -20 degrees C resulted in significantly (P

In Chile, Mycobacterium avium subsp. paratuberculosis ( Map ) has been isolated on several occasions and clinical cases have been reported. Nevertheless, diagnostic tests have not yet been validated for this agent in the Chilean setting. The objective of the study was to validate a commercial ELISA to detect Map shedding dairy cows in management conditions, prevalence and stages of infection existing in Southern Chile, utilising different statistical approaches. Blood and faeces were collected from 1333 lactating cows in 27 dairy herds (both large commercial and smallholder dairy farms) between September 2003 and August 2004. Within the herds up to a maximum of 100 dairy cows were selected based on age (≥3 years old) and, if present, clinical signs of a Map infection. In herds with less than 100 cows, all cows ≥3 years old were sampled. Blood samples were tested using a commercial ELISA kit (IDEXX Laboratories, Inc.). Faecal samples were cultured on Herrold's Egg Yolk Medium (HEYM). Latent class models (i.e. maximum likelihood (ML) methods and Bayesian inference) were used to determine the validity of the ELISA. Map was cultured from 54 (4.1%) cows and 10 (37.0%) herds, which were all large, commercial dairy herds. As a result of empty cells in the cross-tabulations, the ML model provided the same results as the validation with faecal culture as the gold-standard. In the Bayesian model, the Se and Sp of the ELISA were estimated to be 26% (95% CI: 18–35%) and 98.5% (95% CI: 97.4–99.4%), respectively. For faecal culture, the Se was 54% (95% CI: 46–62%) and the Sp was 100% (95% CI: 99.9–100%). Interestingly, the prevalence in the smallholder dairy farms was estimated to be 8% even though there were no faecal culture positive cows detected in those herds. There was no significant correlation between the two tests. The advantage of Bayesian inference is that the Se and Sp of both tests are obtained in one model relative to the (latent) true disease status, the model can handle small datasets and empty cells and the estimates can be corrected for the correlation between tests when the tests are not conditionally independent. Therefore, Bayesian analysis was the preferred method for Map that lacks a gold-standard and usually has low cow-level prevalence.

A total of 1,950 serum samples from dairy cattle in California, USA were tested for the presence of antibodies to Mycobacterium avium subspecies paratuberculosis (MAP) using a commercial enzyme-linked immunosorbent assay (ELISA) kit. The sampled animals came from 65 herds and were sampled to reflect the relative numbers and distribution of dairy herds within three geographic regions in the state. Using the manufacturers suggested cut-off for a positive test, 89 animals (4.6%) were positive. The seroprevalence was 6.9% in the northern region of the state, 3.7% in the central region and 5.2% in the southern region. Using the sensitivity and specificity claimed by the manufacturer of the ELISA kit, the true prevalence in California dairy cattle overall was calculated as 9.4% (99% CI, 7.7%, 11.1%) and the true prevalences for the northern, central and southern regions were 14.1% (99% CI, 9.6%, 18.65%), 7.5% (99% CI, 5.6%, 9.4%), and 10.6% (99% CI, 5.9%, 15.6%), respectively.

Enzootic bovine leukosis (EBL) is an economically important infection of dairy cattle worldwide, which is caused by bovine leukemia virus (BLV). The prevalence of infection in Canadian dairy herds is high and continues to increase; however, there has not been a national program to control BLV. This cross-sectional study was conducted to identify potentially important risk factors for BLV infection on Canadian dairy herds, which is a prerequisite to developing an effective control program. During 1998-2003, based on a stratified two-stage random sampling process, 315 dairy farms from seven provinces of Canada were selected. Within each farm, 9-45 cows were bled and tested with a commercial serum ELISA kit for BLV antibodies. A comprehensive questionnaire, targeting potentially important herd-level management indicators, was successfully administered in 272 herds. A zero-inflated negative binomial (ZINB) regression model was fit to the resulting data to assess the potential associations between BLV seropositivity and a variety of herd-level factors. Seventy-eight percent of the herds were identified as BLV-positive (had one or more test positive animals). In the negative-binomial part of the final ZINB model, herds with clinical cases of leukosis during the 12 months prior to sampling, as well as herds which purchased animals with unknown BLV infection status in the last five years, had a significantly larger proportion of BLV positive animals. Based on a significant interaction between two of the risk factors, changing gloves between cows during pregnancy examination was not statistically associated with lower proportion of infected cows compared with not changing gloves, in the western Canadian provinces. In the logistic part of the model, herds from eastern Canadian provinces and those not purchasing cows in the last five years had increased odds of being free from BLV. The high prevalence of infection across Canada should be addressed through the development and implementation of a nationwide control program which will address the regional and herd-level risk factors for BLV infection identified in this study.

Employing plasma samples rather than serum samples for serological paratuberculosis diagnosis is practical, especially when bovine TB is assessed in the same cattle herd with the gamma interferon bovine avian (IFN-γ BA) test. We demonstrate that antibody titers in serum and plasma samples, utilizing the PARACHECK ® ELISA kit, are highly comparable (Cohen's kappa test, k = 0.955). We conclude that serum can be replaced with plasma in this commercially available antibody detection assay resulting in working hour savings for sampling and blood sample work-up and cost reductions for materials and sample storage.